BR112016014488A2 - Meio para cultura celular - Google Patents
Meio para cultura celularInfo
- Publication number
- BR112016014488A2 BR112016014488A2 BR112016014488A BR112016014488A BR112016014488A2 BR 112016014488 A2 BR112016014488 A2 BR 112016014488A2 BR 112016014488 A BR112016014488 A BR 112016014488A BR 112016014488 A BR112016014488 A BR 112016014488A BR 112016014488 A2 BR112016014488 A2 BR 112016014488A2
- Authority
- BR
- Brazil
- Prior art keywords
- medium
- cell culture
- serum substitute
- culture
- phosphatidylcholine
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title abstract 2
- 239000002609 medium Substances 0.000 abstract 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000012595 freezing medium Substances 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361918833P | 2013-12-20 | 2013-12-20 | |
| PCT/US2014/071388 WO2015095651A1 (en) | 2013-12-20 | 2014-12-19 | Media for cell culture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016014488A2 true BR112016014488A2 (pt) | 2017-08-08 |
Family
ID=53399356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016014488A BR112016014488A2 (pt) | 2013-12-20 | 2014-12-19 | Meio para cultura celular |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9637721B2 (enExample) |
| EP (1) | EP3083978A4 (enExample) |
| JP (1) | JP2017500893A (enExample) |
| KR (1) | KR20160125352A (enExample) |
| CN (1) | CN106062205A (enExample) |
| AR (1) | AR098875A1 (enExample) |
| AU (1) | AU2014364368A1 (enExample) |
| BR (1) | BR112016014488A2 (enExample) |
| CA (1) | CA2934487A1 (enExample) |
| CL (1) | CL2016001553A1 (enExample) |
| EA (1) | EA201691297A1 (enExample) |
| IL (1) | IL246262A0 (enExample) |
| MX (1) | MX2016008251A (enExample) |
| SG (1) | SG11201604994UA (enExample) |
| TW (1) | TW201527534A (enExample) |
| WO (1) | WO2015095651A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10918102B2 (en) | 2014-03-13 | 2021-02-16 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
| EP3674397A1 (en) | 2014-12-30 | 2020-07-01 | Cell Cure Neurosciences Ltd. | Rpe cell populations and methods of generating same |
| CA3001341C (en) | 2015-10-15 | 2024-05-14 | Wake Forest University Health Sciences | Methods of producing in vitro liver constructs and uses thereof |
| AU2016339998B2 (en) | 2015-10-16 | 2022-04-07 | Wake Forest University Health Sciences | Multi-layer airway organoids and methods of making and using the same |
| WO2017096139A1 (en) * | 2015-12-03 | 2017-06-08 | Boston Medical Center Corporation | B cell-based cancer immunotherapy |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695407B (zh) * | 2016-03-15 | 2019-04-16 | 佰通生物技术(苏州)有限公司 | 一种对干细胞具有活化作用的微量元素组合物及其应用 |
| EP3430127A4 (en) * | 2016-03-18 | 2019-09-04 | Institute of Biophysics Chinese Academy of Sciences | CELL CULTURE MEDIUM AND CULTURE MEDIA SUPPLEMENT |
| TWI734775B (zh) | 2016-04-26 | 2021-08-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
| CN106119186B (zh) * | 2016-06-24 | 2019-10-08 | 肇庆大华农生物药品有限公司 | 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法 |
| CN106497872B (zh) * | 2016-12-01 | 2019-10-11 | 北京欣博睿丰医疗科技发展有限公司 | 骨骼肌干细胞无血清培养基及其制备方法和应用 |
| US12087399B2 (en) * | 2017-02-01 | 2024-09-10 | Sapphiros Ai Bio Llc | Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cells |
| CN110494559B (zh) * | 2017-03-28 | 2023-10-31 | 味之素株式会社 | 不分化地维持用培养基添加剂 |
| CN107177542A (zh) * | 2017-05-25 | 2017-09-19 | 句容亿格纳米材料厂 | 一种促进培养基中谷氨酰胺溶解的优化方法 |
| WO2018219684A1 (en) * | 2017-05-31 | 2018-12-06 | Promocell Bioscience Alive Gmbh Biomedizinische Produkte | Culture medium for pluripotent stem cells |
| US12058996B2 (en) * | 2017-06-14 | 2024-08-13 | The General Hospital Corporation | High subzero cryopreservation |
| CN107488625B (zh) * | 2017-08-31 | 2018-12-21 | 广州蕊特生物科技有限公司 | 一种胎牛血清替代物及其制备方法和应用 |
| CN109395095B (zh) * | 2017-09-18 | 2021-09-24 | 武汉原生原代生物医药科技有限公司 | 体内用生物膜及其制备方法和用途 |
| CN111278441A (zh) * | 2017-10-11 | 2020-06-12 | 巴斯特生物技术 | 用于治疗纤维化的组合物和方法 |
| WO2019072889A1 (en) * | 2017-10-13 | 2019-04-18 | Boehringer Ingelheim International Gmbh | MEDIUM OF INFUSION |
| WO2019081609A1 (en) * | 2017-10-24 | 2019-05-02 | Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis) | NANOSYSTEMS FOR CELL PROLIFERATION |
| KR102569522B1 (ko) * | 2017-11-24 | 2023-08-24 | 주식회사 차바이오랩 | 세포 동결 보존용 조성물 및 이를 이용한 세포 동결 보존 방법 |
| AU2018393494A1 (en) * | 2017-12-29 | 2020-07-09 | Cell Cure Neurosciences Ltd. | Retinal pigment epithelium cell compositions |
| US12167729B2 (en) | 2018-05-30 | 2024-12-17 | The General Hospital Corporation | Cryopreservation of tissues and organs |
| CN108853489B (zh) * | 2018-06-29 | 2019-07-02 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv弱毒疫苗的方法 |
| CN108815516B (zh) * | 2018-06-29 | 2019-03-15 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv灭活疫苗的方法 |
| CN109234223B (zh) * | 2018-11-21 | 2021-01-19 | 南京基蛋生物医药有限公司 | 低蛋白无血清细胞培养基 |
| KR102271949B1 (ko) * | 2019-04-15 | 2021-07-02 | 순천향대학교 산학협력단 | 포스파티딜콜린을 함유하는 선충 배양용 조성물 및 이를 이용한 선충의 배양방법 |
| WO2020218584A1 (ja) * | 2019-04-26 | 2020-10-29 | 味の素株式会社 | 細胞培養用組成物 |
| KR102132457B1 (ko) * | 2019-05-10 | 2020-07-09 | 주식회사 바이오솔루션 | 세포외 소포를 고농도로 배양하기 위한 세포 배양배지 및 상기 세포 배양배지를 이용한 세포외 소포 고 함유 조건화 배양액의 제조방법 |
| CN109943526B (zh) * | 2019-05-23 | 2019-09-13 | 广州赛莱拉干细胞科技股份有限公司 | 一种促间充质干细胞增殖的无血清多肽组合物 |
| WO2021078935A1 (en) * | 2019-10-25 | 2021-04-29 | Fundació Centre De Regulació Genòmica | Culture media for mycoplasma |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| US20220378840A1 (en) * | 2019-11-29 | 2022-12-01 | Rutgers, The State University Of New Jersey | Compositions, kits and methods for storage of blood products and methods of use thereof |
| BR112022014275A2 (pt) * | 2020-01-21 | 2022-09-20 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Uso de ativadores de fgf em meios de cultura |
| CN111849860B (zh) * | 2020-06-01 | 2021-12-21 | 浙江大学 | 一种利用铁元素调控肠道干细胞分化的方法及应用 |
| IL298798A (en) * | 2020-06-05 | 2023-02-01 | Upside Foods Inc | Nutrient media for the production of slaughter-free meat |
| CN111534478A (zh) * | 2020-06-24 | 2020-08-14 | 肇庆大华农生物药品有限公司 | 用于培养mdck细胞系的培养基及其制备方法 |
| US20220142150A1 (en) * | 2020-11-10 | 2022-05-12 | Axogen Corporation | Packaging system for a medical product |
| CN112514892B (zh) * | 2020-12-25 | 2022-06-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
| CN112501113B (zh) * | 2021-02-03 | 2021-04-27 | 上海奥浦迈生物科技股份有限公司 | 一种hek293细胞组合梯度培养基及其用途 |
| CN113061584A (zh) * | 2021-05-14 | 2021-07-02 | 赵峻岭 | 一种能促进腺病毒生长的培养基添加物 |
| WO2023014712A1 (en) * | 2021-08-02 | 2023-02-09 | Montana State University | Chemically defined serum replacements for cell culture |
| US11878036B2 (en) | 2022-05-25 | 2024-01-23 | Neuvian LLC | Vaginal care compositions and methods of improving vaginal health |
| EP4563695A1 (en) * | 2022-07-28 | 2025-06-04 | Sanyo-Onoda City Public University Corporation | Composition for cryopreservation, cryopreservation method, and frozen cell or biological tissue |
| KR20240177180A (ko) * | 2023-06-19 | 2024-12-27 | (주)엑셀세라퓨틱스 | T 세포 배양용 배지 조성물 |
| WO2025098952A1 (en) | 2023-11-07 | 2025-05-15 | Evonik Operations Gmbh | Nutrient preloading of cells |
| WO2025199245A1 (en) * | 2024-03-19 | 2025-09-25 | Immunis, Inc. | Method of making and using secretome composition |
| US12421441B1 (en) | 2025-05-19 | 2025-09-23 | King Fahd University Of Petroleum And Minerals | Method for microbially enhanced oil recovery |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721676A (en) | 1982-12-14 | 1988-01-26 | Genencor, Inc. | Novel thermophile isolate having thermostable hydrolytic activity |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| DE3827578A1 (de) | 1988-08-13 | 1990-02-15 | Siepmann Friedrich W | Verfahren und vorrichtung zur bestimmung oxidierbarer wasserinhaltsstoffe einer waessrigen probenfluessigkeit |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| US5834312A (en) | 1990-01-29 | 1998-11-10 | Hy-Gene, Inc. | Process and media for the growth of human epithelia |
| US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| WO1997006784A1 (en) | 1995-08-15 | 1997-02-27 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
| DE69637625D1 (de) * | 1995-10-19 | 2008-09-18 | Bio Origyn Llc | Methoden und zusammensetzungen, die das ueberleben und die funktion von keimbahnzellen und embryonen verbessern |
| EP2221361A3 (en) | 1996-08-30 | 2011-02-09 | Life Technologies Corporation | Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| ATE399855T1 (de) | 1996-10-10 | 2008-07-15 | Invitrogen Corp | Tierzellkulturmedium mit pflanzlichen nährstoffen |
| US6833271B2 (en) * | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
| US5985538A (en) | 1997-08-01 | 1999-11-16 | Saint Barnabas Medical Center | Cryopreservation and cell culture medium comprising less than 50 mM sodium ions and greater than 100 mM choline salt |
| GB9817805D0 (en) | 1998-08-14 | 1998-10-14 | Danisco | Use of a composition |
| PT1226233E (pt) | 1999-08-05 | 2011-10-04 | Abt Holding Co | Células estaminais adultas multipotentes e métodos para isolamento |
| US7112576B1 (en) * | 1999-12-10 | 2006-09-26 | Regents Of The University Of Minnesota | Compositions and methods for cryopreservation of peripheral blood lymphocytes |
| US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| US7169610B2 (en) | 2002-01-25 | 2007-01-30 | Genzyme Corporation | Serum-free media for chondrocytes and methods of use thereof |
| EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
| EP1711053A2 (en) | 2004-02-02 | 2006-10-18 | I.M.T. Interface Multigrad Technology Ltd. | Biological material and methods and solutions for preservation thereof |
| US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| US20050287666A1 (en) | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
| EP2267116B1 (en) | 2004-07-13 | 2017-05-31 | Asterias Biotherapeutics, Inc. | Growth medium for primate embryonic stem cells |
| WO2006045064A2 (en) | 2004-10-20 | 2006-04-27 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
| ATE499434T1 (de) | 2004-11-02 | 2011-03-15 | Ares Trading Sa | Serumfreies kulturmedium für säugerzellen |
| WO2006079205A1 (en) | 2005-01-28 | 2006-08-03 | Canadian Blood Services | A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
| WO2007016366A2 (en) | 2005-07-29 | 2007-02-08 | Yale University | Defined culture conditions of human embryonic stem cells |
| WO2007071389A1 (en) | 2005-12-21 | 2007-06-28 | Sentoclone Ab | Method for treating disseminated cancer |
| AU2007220759A1 (en) | 2006-02-23 | 2007-09-07 | Viacyte, Inc. | Compositions and methods useful for culturing differentiable cells |
| JP5080779B2 (ja) * | 2006-10-25 | 2012-11-21 | テルモ株式会社 | リポソーム製剤の製造方法 |
| JP2010525836A (ja) | 2007-05-04 | 2010-07-29 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | ヒト造血幹細胞のｅｘｖｉｖｏ増殖 |
| WO2009023194A2 (en) | 2007-08-10 | 2009-02-19 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| EA201490945A1 (ru) * | 2011-11-11 | 2014-08-29 | ЭССЕНШЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Набор, содержащий заменитель сыворотки и лабильные факторы |
-
2014
- 2014-12-19 BR BR112016014488A patent/BR112016014488A2/pt not_active IP Right Cessation
- 2014-12-19 AU AU2014364368A patent/AU2014364368A1/en not_active Abandoned
- 2014-12-19 CN CN201480075947.7A patent/CN106062205A/zh active Pending
- 2014-12-19 EA EA201691297A patent/EA201691297A1/ru unknown
- 2014-12-19 JP JP2016560860A patent/JP2017500893A/ja active Pending
- 2014-12-19 WO PCT/US2014/071388 patent/WO2015095651A1/en not_active Ceased
- 2014-12-19 CA CA2934487A patent/CA2934487A1/en not_active Abandoned
- 2014-12-19 SG SG11201604994UA patent/SG11201604994UA/en unknown
- 2014-12-19 KR KR1020167019241A patent/KR20160125352A/ko not_active Withdrawn
- 2014-12-19 MX MX2016008251A patent/MX2016008251A/es unknown
- 2014-12-19 EP EP14870754.0A patent/EP3083978A4/en not_active Withdrawn
- 2014-12-19 US US14/577,414 patent/US9637721B2/en not_active Expired - Fee Related
- 2014-12-19 TW TW103144675A patent/TW201527534A/zh unknown
- 2014-12-19 AR ARP140104810A patent/AR098875A1/es unknown
-
2016
- 2016-06-16 IL IL246262A patent/IL246262A0/en unknown
- 2016-06-16 CL CL2016001553A patent/CL2016001553A1/es unknown
-
2017
- 2017-03-28 US US15/471,621 patent/US20170198251A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3083978A4 (en) | 2017-08-30 |
| US20170198251A1 (en) | 2017-07-13 |
| IL246262A0 (en) | 2016-07-31 |
| SG11201604994UA (en) | 2016-07-28 |
| KR20160125352A (ko) | 2016-10-31 |
| CN106062205A (zh) | 2016-10-26 |
| AR098875A1 (es) | 2016-06-22 |
| EA201691297A1 (ru) | 2016-11-30 |
| TW201527534A (zh) | 2015-07-16 |
| AU2014364368A1 (en) | 2016-07-07 |
| CA2934487A1 (en) | 2015-06-25 |
| WO2015095651A1 (en) | 2015-06-25 |
| EP3083978A1 (en) | 2016-10-26 |
| US20150175956A1 (en) | 2015-06-25 |
| US9637721B2 (en) | 2017-05-02 |
| MX2016008251A (es) | 2016-10-13 |
| JP2017500893A (ja) | 2017-01-12 |
| CL2016001553A1 (es) | 2017-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016014488A2 (pt) | Meio para cultura celular | |
| ES2523998T3 (es) | Método de aislamiento de citoblastos dérmicos | |
| BR112015006546B8 (pt) | Entidade descontínua tridimensional, métodos para fabricar uma entidade descontõnua tridimensional, para fabricar uma matriz de cultura celular, para transportar c lulas, e para cultura tridimensional ou bidimensional de c lulas ou tecidos, matriz de cultura celular, artigo para cultura celular, uso de uma entidade descontõnua tridimensional ou de um artigo, e, kit | |
| BR112015023515A8 (pt) | construtos de tecido hepático tridimensionais vivos engenheirados, métodos para fabricá-los e uso destes para aumentar uma ou mais funções hepáticas em um ser humano | |
| BR112017018885A2 (pt) | método de cultura celular para células-tronco mesenquimais | |
| BR112015001620A2 (pt) | composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição | |
| MX2016004564A (es) | Cultivo celular metabolicamente optimizado. | |
| BR112013002811A8 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
| BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
| BR112014031424A2 (pt) | tratamento de células pluripotentes | |
| MX2015007361A (es) | Produccion mediada por la proteina portadora de acilo de los derivados de acidos grasos. | |
| BR112016004510A2 (pt) | composições bioativas deriváveis de concentrados de plaquetas e métodos para preparar e usar as mesmas | |
| BR112014013912A2 (pt) | carne moída alternativa baseada em vegetal | |
| WO2014200997A3 (en) | Method for preparing three-dimensional, organotypic cell cultures and uses thereof | |
| HK1202133A1 (en) | Kit comprising serum replacement and labile factors | |
| EA201590550A1 (ru) | Композиции и способы получения гликопротеинов | |
| BR112015020904A2 (pt) | microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato | |
| BR112014032544A2 (pt) | método para produzir iduronato-2-sulfatase recombinante | |
| MX2016005824A (es) | Metodo de cultivo celular. | |
| AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
| BRPI1003783A2 (pt) | Meio de cultura de células de mamíferos que compreende sobrenadante de estágios de fracionamento de cohn, seu processo de preparação e uso | |
| BR112016008538A2 (pt) | suplementação de nucleosídeos para promover a função celular, estabilidade genética e aplicações regenerativa | |
| AU336901S (en) | An escutcheon | |
| AU343717S (en) | Sticking plaster used for medical purposes | |
| BR112014011198A2 (pt) | dispositivos e métodos para aumento da viabiliade de bactérias em forma de bastonete |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: BIO-ESS LABORATORIES, LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2545 DE 15-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |